Search Results - "Moyano‐Galceran, Lidia"
-
1
Adaptive RSK‐EphA2‐GPRC5A signaling switch triggers chemotherapy resistance in ovarian cancer
Published in EMBO molecular medicine (07-04-2020)“…Metastatic cancers commonly activate adaptive chemotherapy resistance, attributed to both microenvironment‐dependent phenotypic plasticity and genetic…”
Get full text
Journal Article -
2
Aggressive and recurrent ovarian cancers upregulate ephrinA5, a non-canonical effector of EphA2 signaling duality
Published in Scientific reports (23-04-2021)“…Erythropoietin producing hepatocellular (Eph) receptors and their membrane-bound ligands ephrins are variably expressed in epithelial cancers, with…”
Get full text
Journal Article -
3
Mechanical Confinement and DDR1 Signaling Synergize to Regulate Collagen‐Induced Apoptosis in Rhabdomyosarcoma Cells
Published in Advanced science (01-10-2022)“…Fibrillar collagens promote cell proliferation, migration, and survival in various epithelial cancers and are generally associated with tumor aggressiveness…”
Get full text
Journal Article -
4
FOXP3+ T cells in uterine sarcomas are associated with favorable prognosis, low extracellular matrix expression and reduced YAP activation
Published in NPJ precision oncology (19-11-2021)“…Uterine sarcomas are rare but deadly malignancies without effective treatment. Immunotherapy is a promising new approach to treat these tumors but has shown…”
Get full text
Journal Article -
5
Fibroblasts in the Tumor Microenvironment: Shield or Spear?
Published in International journal of molecular sciences (21-05-2018)“…Tumorigenesis is a complex process involving dynamic interactions between malignant cells and their surrounding stroma, including both the cellular and…”
Get full text
Journal Article -
6
Co-evolution of matrisome and adaptive adhesion dynamics drives ovarian cancer chemoresistance
Published in Nature communications (23-06-2021)“…Due to its dynamic nature, the evolution of cancer cell-extracellular matrix (ECM) crosstalk, critically affecting metastasis and treatment resistance, remains…”
Get full text
Journal Article -
7
Chemotherapy as a regulator of extracellular matrix-cell communication: Implications in therapy resistance
Published in Seminars in cancer biology (01-11-2022)“…The development of most solid cancers, including pancreatic, breast, lung, liver, and ovarian cancer, involves a desmoplastic reaction: a process of major…”
Get full text
Journal Article -
8
Crosstalk Between Cancer Associated Fibroblasts and Cancer Cells in Scirrhous Type Gastric Cancer
Published in Frontiers in oncology (16-10-2020)“…Gastric cancer (GC) is the third leading cause among all cancer deaths globally. Although the treatment outcome of GC has improved, the survival of patients…”
Get full text
Journal Article -
9
Single-cell transcriptomes identify patient-tailored therapies for selective co-inhibition of cancer clones
Published in Nature communications (03-10-2024)“…Intratumoral cellular heterogeneity necessitates multi-targeting therapies for improved clinical benefits in advanced malignancies. However, systematic…”
Get full text
Journal Article -
10
Molecular, cellular and systemic aspects of epithelial ovarian cancer and its tumor microenvironment
Published in Seminars in cancer biology (01-11-2022)“…Ovarian cancer encompasses a heterogeneous group of malignancies that involve the ovaries, fallopian tubes and the peritoneal cavity. Despite major advances…”
Get full text
Journal Article -
11
Mesothelin-specific CAR T cells target ovarian cancer
Published in Cancer research (Chicago, Ill.) (01-06-2021)“…New therapeutic options for patients with ovarian cancer are urgently needed. Therefore, we evaluated the efficacy of two second-generation mesothelin…”
Get full text
Journal Article -
12
Abstract PO050: EphA2 signaling segregation and modulation by diverse tumor microenvironment components differentially regulates cancer cell invasion and survival
Published in Cancer research (Chicago, Ill.) (01-03-2021)“…Abstract The receptor tyrosine kinase EphA2 is overexpressed in many solid cancers and associated with disease aggressiveness and poor clinical outcome. EphA2…”
Get full text
Journal Article -
13
Abstract GMM-041: OVARIAN CANCER CELLS INDUCE A FEEDBACK RESPONSE TO PLATINUM-BASED CHEMOTHERAPY BY ACTIVATING AN ONCOGENIC RSK-EPHA2-GPRC5A SIGNALING SWITCH
Published in Clinical cancer research (15-11-2019)“…Abstract Despite increased understanding of chemotherapy resistance, the effects of the chemotherapy itself on the oncogenic cancer cell properties and…”
Get full text
Journal Article -
14
Efficacy and safety of glycosphingolipid SSEA-4 targeting CAR-T cells in an ovarian carcinoma model
Published in Molecular cancer therapeutics (01-11-2023)“…Chimeric antigen receptor (CAR) T-cell immunotherapies for solid tumors face critical challenges such as heterogeneous antigen expression. We characterized…”
Get full text
Journal Article -
15
Thermal Proteome Profiling Identifies Oxidative-Dependent Inhibition of the Transcription of Major Oncogenes as a New Therapeutic Mechanism for Select Anticancer Compounds
Published in Cancer research (Chicago, Ill.) (01-04-2020)“…Identification of the molecular mechanism of action (MoA) of bioactive compounds is a crucial step for drug development but remains a challenging task despite…”
Get full text
Journal Article -
16
Receptor Tyrosine Kinase Signaling and Extracellular Matrix Cues in Ovarian Cancer Metastasis and Drug Resistance
Published 01-01-2021“…Albeit many studies have contributed towards understanding the origin, development, treatment response and evolution of high-grade serous ovarian carcinoma…”
Get full text
Dissertation -
17
Abstract A64: Extracellular matrix proteins increase invasive growth and chemotherapy resistance of ovarian cancer cells
Published in Clinical cancer research (01-07-2020)“…Abstract Extracellular matrix (ECM) interactions contribute to cancer metastasis and chemotherapy resistance by regulating invasive cancer growth and apoptosis…”
Get full text
Journal Article -
18
Integrated Molecular Analysis of Undifferentiated Uterine Sarcomas Reveals Clinically Relevant Molecular Subtypes
Published in Clinical cancer research (01-04-2019)“…Undifferentiated uterine sarcomas (UUS) are rare, extremely deadly, sarcomas with no effective treatment. The goal of this study was to identify novel…”
Get full text
Journal Article